Identification of factors predictive of malignancy in patients with atypical biliary brushing results obtained via ERCP

Diagnostic Cytopathology

Volumn 41, Issue 8, 2013, Pages 682-688

  Witt, Benjamin L ^a   Kristen Hilden, R N ^a   Scaife, Courtney ^a   Chadwick, Barbara ^a   Layfield, Lester ^a   Cory Johnston, W ^a   Safaee, Maryam ^a   Siddiqui, Ali ^b   Adler, Douglas G ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

biliary; brushing; cytology; ERCP

Indexed keywords

CA 19-9 ANTIGEN;

ADULT; AGED; ARTICLE; COMMON BILE DUCT; DEMOGRAPHY; ELECTRONIC MEDICAL RECORD; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FOLLOW UP; HEPATIC DUCT; HUMAN; JAUNDICE; MAJOR CLINICAL STUDY; MALE; PATHOLOGIST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SEROLOGY;

EID: 84881382769     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.22924     Document Type: Article

References (23)

1. Okonkwo AM, De Frias DV, Gunn R, Diaz L, Schindler S, Lal A, Nayar R,. Reclassification of "atypical" diagnoses in endoscopic retrograde cholangiopancreaticography-guided biliary brushings. Acta Cytol 2003; 47: 435-442. (Pubitemid 36588452)
2. Layfield LJ, Wax TD, Lee JG, Cotton PB,. Accuracy and morphologic aspects of pancreatic and biliary duct brushings. Acta Cytol 1995; 39: 11-18.
3. Kocjan G, Smith AN,. Bile duct brushings cytology: Potential pitfalls in diagnosis. Diagn Cytopathol 1997; 16: 358-363. (Pubitemid 27197713)
4. Lal A, Okonkwo A, Schindler S, De Frias D, Nayar R,. Role of biliary brush cytology in primary sclerosing cholangitis. Acta Cytol 2004; 48: 9-12. (Pubitemid 38166505)
5. Urbano M, Rosa A, Gomes D, Camacho E, Calhau CA, Leitão M,. Team approach to ERCP-directed single-brush cytology for the diagnosis of malignancy. Rev Esp Enferm Dig 2008; 100: 462-465.
6. Volmar KE, Vollmer RT, Routbort MJ, Creager AJ,. Pancreatic and bile duct brushing cytology in 1000 cases: Review of findings and comparison of preparation methods. Cancer 2006; 108: 231-238. (Pubitemid 44835770)
7. Renshaw AA, Madge R, Jiroutek M, Granter SR,. Bile duct brushing cytology: Statistical analysis of proposed diagnostic criteria. Am J Clin Pathol 1998; 110: 635-640. (Pubitemid 28491969)
8. Stewart CJ, Mills PR, Carter R, O'Donohue J, Fullarton G, Imrie CW, Murray WR,. Brush cytology in the assessment of pancreatico-biliary strictures: A review of 406 cases. J Clin Pathol 2001; 54: 449-455. (Pubitemid 32531094)
9. Govil H, Reddy V, Kluskens L, Treaba D, Massarani-Wafai R, Selvaggi S, Gattuso P,. Brush cytology of the biliary tract: Retrospective study of 278 cases with histopathologic correlation. Diagn Cytopathol 2002; 26: 273-277. (Pubitemid 34492477)
10. Rustagi T, Dasanu CA,. Risk factors for gallbladder cancer and cholangiocarcinoma: Similarities, differences and updates. J Gastrointest Cancer 2012;43:137-147. PubMed PMID: 21597894.
11. Chapman RW,. Risk factors for biliary tract carcinogenesis. Ann Oncol 1999: 10 (Suppl 4): 308-311.
12. Gold EB, Goldin SB,. Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin N Am 1998; 7: 67.
13. Park SY, Roh SJ, Kim YN, Kim SZ, Park HS, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS,. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: Prognostic impact. Oncol Rep 2009; 22: 649-657.
14. Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD,. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 2008; 48: 1106-1117.
15. Lindberg B, Arnelo U, Bergquist A, Thörne A, Hjerpe A, Granqvist S, Hansson LO, Tribukait B, Persson B, Broomé U,. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy 2002; 34: 909-916. (Pubitemid 35331183)
16. Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R,. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108: 865-869.
17. Nakeeb A, Lipsett PA, Lillemoe KD, Fox-Talbot MK, Coleman J, Cameron JL, Pitt HA,. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am J Surg 1996; 171: 147-152; discussion 152-153. (Pubitemid 126349889)
18. Björnsson E, Kilander A, Olsson R,. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 1999; 19: 501-508. (Pubitemid 30019064)
19. Hultcrantz R, Olsson R, Danielsson A, Järnerot G, Lööf L, Ryden BO, Wahren B, Broomé U,. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol 1999; 30: 669-673. (Pubitemid 29151909)
20. Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M,. Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol 2011; 17: 867-897; Review.
21. Siqueira E, Schoen RE, Silverman W, Martin J, Rabinovitz M, Weissfeld JL, Abu-Elmaagd K, Madariaga JR, Slivka A,. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc 2002; 56: 40-47. Erratum in: Gastrointest Endosc 2002;56:612. (Pubitemid 41115047)
22. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, de Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR,. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 2004; 99: 1675-16781.
23. Rabinovitz M, Zajko AB, Hassanein T, Shetty B, Bron KM, Schade RR, Gavaler JS, Block G, Van Thiel DH, Dekker A,. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: A study in 65 patients with bile duct strictures. Hepatology 1990; 12 (4 Part 1): 747-752. (Pubitemid 20349261)